Vitamin D 25 ng/mL — the ceiling your doctor calls "normal"
A 25-hydroxyvitamin D level of 25 ng/mL (62.5 nmol/L) sits exactly at the boundary the Institute of Medicine and most NHS / commercial-lab reports call "sufficient" — meaning bone health is unlikely to be acutely compromised. However, the Endocrine Society and a substantial body of research literature target 40–60 ng/mL (100–150 nmol/L) as optimal for non-skeletal endpoints: immune regulation, insulin sensitivity, mood, and inflammation markers. A reading of 25 is where the bar is set so low that almost no one is technically deficient — but where the upside of correction is also greatest.
Reference ranges
| Severe deficiency | < 12 ng/mL (< 30 nmol/L) |
| Deficiency | 12 – 20 ng/mL |
| Insufficiency | 20 – 30 ng/mL |
| Sufficient (IOM minimum) | ≥ 20 ng/mL |
| Optimal (Endocrine Society / research) | 40 – 60 ng/mL |
| Toxicity threshold | > 100 ng/mL |
What this marker measures
Serum 25-hydroxyvitamin D [25(OH)D] is the storage form of vitamin D and the standard biomarker of vitamin D status. It is produced when ultraviolet B radiation strikes 7-dehydrocholesterol in skin (cholecalciferol → liver hydroxylation → 25(OH)D) or when dietary D2/D3 is ingested. The active hormone — 1,25-dihydroxyvitamin D — has a much shorter half-life and is tightly regulated, so it isn't useful as a status marker. 25(OH)D's half-life is ~2–3 weeks, making it a stable proxy for the past 6–8 weeks of intake + sun exposure.
Why might it be low?
- ·Latitudes above 35° during winter (UVB insufficient for skin synthesis)
- ·Indoor lifestyle / consistent sunscreen use
- ·Darker skin pigmentation (melanin reduces UVB penetration ~3–5×)
- ·Adiposity — fat-soluble vitamin D is sequestered in adipose tissue
- ·Older age (skin synthesis efficiency drops 50%+ after 70)
- ·Malabsorption (coeliac, IBD, post-bariatric surgery)
- ·CYP2R1 / VDR genetic variants reducing conversion or receptor binding
Why might it be elevated?
- ·Aggressive D3 supplementation (typically >5,000 IU/d for months)
- ·Excessive UV exposure (rare to push much past 60 ng/mL via sun alone)
- ·Granulomatous diseases (sarcoidosis) — increased peripheral conversion
- ·Lab assay variability — different labs disagree by ±20%
Compounds whose research literature has investigated this area
These are research-grade compounds in our catalogue whose published study literature touches the same biology. Listed for research context — not as recommendations for self-administration.
Nicotinamide adenine dinucleotide — the coenzyme central to cellular electron-transfer, sirtuin signalling, and redox biology.
MOTS-c is a 16-residue peptide encoded in the mitochondrial 12S rRNA region. Described by the Cohen lab in 2015 — studied in metabolic and exercise biology.
FAQ
Is 25 ng/mL going to make me sick?+
Probably not in the acute sense — bone metabolism is largely protected at this level. But cohort studies consistently associate 25(OH)D below 30 ng/mL with higher cardiovascular events, infectious-disease severity, and depression. The argument for correction is about long-term endpoints, not next-week symptoms.
How much D3 do I need to get to 40+?+
Research literature suggests 800–2,000 IU/d sustains most adults at 30–40 ng/mL; 2,000–4,000 IU/d is typically required to reach 40–60. K2 (MK-7, ~100 mcg/d) is often paired in supplementation literature for calcium-trafficking. Retest after 8–12 weeks.
Should I get sun instead?+
Both work. ~10–20 minutes of midday whole-arms-and-legs sun in summer at UK/EU latitudes generates ~5,000–10,000 IU. In winter (October–March north of 35°N) the UVB angle is too low and supplementation is the only realistic option.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →